SUMMARY OF SIGNIFICANT ACCOUTING POLICIES AND RELATED MATTERS (Details Narrative) (USD $)	12 Months Ended
Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013 Scientific Nanomemdicine, Inc [Member]	Dec. 31, 2012 Scientific Nanomemdicine, Inc [Member]	Dec. 31, 2013 Los Alamos National Security LLC Member	Dec. 31, 2012 Los Alamos National Security LLC Member
Accumulated amortization	$ 164,000	$ 134,000	$ 337,000	$ 207,000	$ 16,000	$ 13,000
Research and development costs	960,000	274,000
Fair value of the Company available for sale securities	$ 0	$ 22,000

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details